Amicus Therapeutics is headquartered in Princeton, New Jersey.
Amicus Therapeutics disclosed revenue of 528M USD for 2024 and 399M USD for 2023.
Amicus Therapeutics is a life science company.
Amicus Therapeutics was founded in 2002.
47 Hulfish Street,
Princeton, New Jersey
08542
United States,
(609) 662-2000
www.amicusrx.com
Amicus Therapeutics is a biotechnology company at the forefront of therapies for rare and orphan diseases. Amicus Therapeutics was founded in 2002 and is based in Princeton, New Jersey.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 2 | - | - | - | - | - | 2 |
| vol | $404M | $404M | ||||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 2 | ||||||||
| Financial | Deals |
|---|---|
|
Leerink Partners |
1 |
| Legal | Deals |
|---|---|
|
Skadden, Arps, Slate, Meagher & Flom |
2 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
